TLR4 and metabolic dysfunction-associated steatotic liver disease: The results showed that MP-A had a good regulatory effect on GM and its metabolites in NAFLD model rats, not only ameliorating the imbalance of intestinal flora in rats but also inhibiting the expression of TLR4 and NF-κB in hepatocytes and the expression of downstream inflammatory factors.